All in One Set of Hands

3449

By: Radha McLean

Islet Technology Inc., a research company based in St. Paul, Minnesota, has acquired all co-owned rights to patents related to encapsulated cell therapy.

Thirteen of those patents are licensed on an exclusive basis from the University of California. Seven of the 13 were previously co-owned by Metabolex Inc., of Hayward, California. Islet Technology Inc. now has 15 patents for encapsulated cell therapy granted and three more pending in its patent portfolio. Encapsulated cell therapy is a method of islet transplantation that doesn’t require the use of anti-rejection drugs.

Comments

comments

Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.